Marialuisa Sponziello1, Giuseppe Damante2, Catia Mio3, Antonella Verrienti1, Valeria Pecce1. 1. Department of Translational and Precision Medicine, "Sapienza" University of Rome, 00161, Rome, Italy. 2. Department of Medicine, University of Udine, 33100, Udine, Italy. 3. Department of Medicine, University of Udine, 33100, Udine, Italy. catia.mio@uniud.it.
Abstract
BACKGROUND: Understanding the molecular mechanisms underlying papillary thyroid cancer (PTC) proved to be vital not only for diagnostic purposes but also for tailored treatments. Despite the strong evidence of heritability, only a small subset of alterations has been implicated in PTC pathogenesis. To this reason, we used targeted next-generation sequencing (NGS) to identify candidate variants implicated in PTC pathogenesis, progression, and invasiveness. METHODS: A total of 42 primary PTC tissues were investigated using a targeted next-generation sequencing (NGS) panel enlisting 47 genes involved in DNA repair and tumor progression. RESULTS: We identified 57 point mutations in 78.5% of samples (n = 32). Thirty-two somatic mutations were identified exclusively in known thyroid cancer genes (BRAF, KRAS, NRAS, and TERT). Unpredictably, 45% of the all identified mutations (n = 25) resulted to be germline, most affecting DNA repair genes. Interestingly, none of the latter variants was in the main population databases. Following ACMG classification, 20% of pathogenic/likely pathogenic and 68% of variant of unknown significance were identified. CONCLUSIONS: Overall, our results support the hypothesis that rare germline variants in DNA repair genes are accountable for PTC susceptibility. More data, including the segregation analysis in affected families, should be collected before definitely annotate these alterations and to establish their potential prognostic and treatment implications.
BACKGROUND: Understanding the molecular mechanisms underlying papillary thyroid cancer (PTC) proved to be vital not only for diagnostic purposes but also for tailored treatments. Despite the strong evidence of heritability, only a small subset of alterations has been implicated in PTC pathogenesis. To this reason, we used targeted next-generation sequencing (NGS) to identify candidate variants implicated in PTC pathogenesis, progression, and invasiveness. METHODS: A total of 42 primary PTC tissues were investigated using a targeted next-generation sequencing (NGS) panel enlisting 47 genes involved in DNA repair and tumor progression. RESULTS: We identified 57 point mutations in 78.5% of samples (n = 32). Thirty-two somatic mutations were identified exclusively in known thyroid cancer genes (BRAF, KRAS, NRAS, and TERT). Unpredictably, 45% of the all identified mutations (n = 25) resulted to be germline, most affecting DNA repair genes. Interestingly, none of the latter variants was in the main population databases. Following ACMG classification, 20% of pathogenic/likely pathogenic and 68% of variant of unknown significance were identified. CONCLUSIONS: Overall, our results support the hypothesis that rare germline variants in DNA repair genes are accountable for PTC susceptibility. More data, including the segregation analysis in affected families, should be collected before definitely annotate these alterations and to establish their potential prognostic and treatment implications.
Authors: Sandya Liyanarachchi; Julius Gudmundsson; Egil Ferkingstad; Huiling He; Jon G Jonasson; Vinicius Tragante; Folkert W Asselbergs; Li Xu; Lambertus A Kiemeney; Romana T Netea-Maier; Jose I Mayordomo; Theo S Plantinga; Hannes Hjartarson; Jon Hrafnkelsson; Erich M Sturgis; Pamela Brock; Fadi Nabhan; Gudmar Thorleifsson; Matthew D Ringel; Kari Stefansson; Albert de la Chapelle Journal: Proc Natl Acad Sci U S A Date: 2020-03-04 Impact factor: 11.205
Authors: Ralph P Tufano; Gilberto V Teixeira; Justin Bishop; Kathryn A Carson; Mingzhao Xing Journal: Medicine (Baltimore) Date: 2012-09 Impact factor: 1.889
Authors: Marta Codrich; Marina Comelli; Matilde Clarissa Malfatti; Catia Mio; Dilara Ayyildiz; Chi Zhang; Mark R Kelley; Giovanni Terrosu; Carlo E M Pucillo; Gianluca Tell Journal: DNA Repair (Amst) Date: 2019-08-07
Authors: Jaroslaw Jendrzejewski; Sandya Liyanarachchi; Rebecca Nagy; Leigha Senter; Paul E Wakely; Andrew Thomas; Fadi Nabhan; Huiling He; Wei Li; Krzysztof Sworczak; Matthew D Ringel; Lawrence S Kirschner; Albert de la Chapelle Journal: Thyroid Date: 2016-07-22 Impact factor: 6.568
Authors: Ilir Agalliu; Miia Suuriniemi; Ludmila Prokunina-Olsson; Bo Johanneson; Francis S Collins; Janet L Stanford; Elaine A Ostrander Journal: Prostate Date: 2008-05-15 Impact factor: 4.104
Authors: Federica Baldan; Catia Mio; Lorenzo Allegri; Ketty Conzatti; Barbara Toffoletto; Cinzia Puppin; Slobodanka Radovic; Carlo Vascotto; Diego Russo; Carla Di Loreto; Giuseppe Damante Journal: Oncotarget Date: 2016-09-27